FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,828,000 | -53.6% | 376,460 | +2.2% | 0.02% | -57.4% |
| Q3 2022 | $8,256,000 | +43.2% | 368,437 | +58.3% | 0.05% | +50.0% |
| Q2 2022 | $5,766,000 | -34.6% | 232,702 | +2.3% | 0.04% | -20.0% |
| Q1 2022 | $8,823,000 | -31.8% | 227,576 | +5.7% | 0.04% | -21.1% |
| Q4 2021 | $12,935,000 | -15.8% | 215,344 | -16.9% | 0.06% | -17.4% |
| Q3 2021 | $15,358,000 | -35.1% | 259,136 | -5.0% | 0.07% | -32.4% |
| Q2 2021 | $23,673,000 | +0.6% | 272,766 | -5.1% | 0.10% | -1.9% |
| Q1 2021 | $23,532,000 | – | 287,295 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |